A place for everyone at the table with MemorySPEX
By Kim Lavine, Founder/CEO of Hypersence, maker of MemorySPEX®
We’re in the midst of an AI revolution. Right now, AI is a tool—the true force multiplier is the human brain. No one knows exactly where AI is headed, but for now, the brain is still king.
We’ve seen this story before.
The printing press sparked the Age of Enlightenment and unprecedented prosperity.
The Industrial Revolution created dynasties and made millions wealthy for the first time in history.
The internet launched first movers into positions of global influence and generational wealth.
Every paradigm shift creates a once-in-a-lifetime opening for those who recognize it—and act. This is that moment again, only faster.
AI is leveling the playing field by expanding access to knowledge and output. In plain terms: opportunity is being democratized. There’s a place for everyone at this table of historic success.
Those who move now will win big. Those who wait will watch from the sidelines. This is your chance to build generational wealth and lasting happiness—for yourself and your family—by being first. And it starts with your brain.
If you’ve used AI, you already know: garbage in, garbage out. The quality of the output depends on the quality of the input. Sharper cognition produces better prompts, better decisions, and better results. The clearest thinkers, fastest learners, and sharpest minds will capture the upside of this historic moment.
I’m betting on the brain. AI won’t set you apart—your brain will.
That’s why we built MemorySPEX®—a patent-pending wearable that uses light + AI to clear harmful plaque accumulations and increase blood flow, improving cognitive performance by up to 50%—as easy as putting on glasses. No pills. No invasive procedures. Just daily sessions designed to elevate memory, focus, and learning speed—so AI becomes your supercharger, not your crutch.
We’ve been validated by science and the market:
Winner of Stanford’s Chairman’s Choice award, competing with top startups worldwide.
Backed by five doctor investor/advisors.
Entering the market as an FDA General Wellness device, competing with the $14B brain-health supplement category.
Positioned to file as a Predicate Device for Alzheimer’s and dementia treatment.
You can’t invest in the dominant AI platforms today. But you can invest where it matters most: in yourself—and in technology that amplifies human cognition.
Our mission is simple: help people achieve dreams of a better life by giving them the cognitive edge to win in an AI-driven world.
Future advantage starts now. We’re launching MemorySPEX at CES in January—but you can get on the waitlist today. Don’t wait for the rush.
👉 Join the First-Mover List for priority preorder access + product updates.
P.S. Investors who believe the next decade belongs to the sharpest minds—reach out to reserve allocation and receive our deck. This is how you back the cognitive edge of the AI era.